title: Lobbying by Big Pharma, bottlenecks for clinical research, and loosening of ethical standards in Brazil--The authors reply.
authors.forename: Marisa
authors.initials: M
authors.lastname: Palácios
authors.forename: Sergio
authors.initials: S
authors.lastname: Rego
mesh_terms: D035843:Biomedical Research; D001938:Brazil; D004345:Drug Industry / Q000941:ethics*; D006801:Humans; D008119:Lobbying